Spyre Therapeutics
SYRE
#4930
Rank
NZ$2.47 B
Marketcap
$42.17
Share price
3.16%
Change (1 day)
46.09%
Change (1 year)

Earnings for Spyre Therapeutics (SYRE)

Earnings in 2024 (TTM): -NZ$0.32 Billion

According to Spyre Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$0.23 Billion a decrease over its 2022 earnings that were of -NZ$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spyre Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.32 Billion38.76%
2023 -NZ$0.23 Billion51.64%
2022 -NZ$0.15 Billion29.14%
2021 -NZ$0.12 Billion-19.43%
2020 -NZ$0.15 Billion1.43%
2019 -NZ$0.15 Billion76.7%
2018 -NZ$80.35 Million64.27%
2017 -NZ$48.92 Million26.34%
2016 -NZ$38.72 Million93.6%
2015 -NZ$20 Million27.08%
2014 -NZ$15.74 Million